Deliver Your News to the World

Investment in Setsuro Tech Inc.

Creating Synergy in the Field of Cell Production Biotechnology


TOKYO – WEBWIRE –

Nikon Corporation (Nikon) is pleased to announce that it has made an investment in Setsuro Tech Inc. (CEO: Shinichiro Takezawa) through the Nikon SBI Innovation Fund II* corporate venture capital fund.

Setsuro Tech Inc. is a biotechnology startup originating from Tokushima University that develops businesses related to research support services and precision breeding utilizing its proprietary genome editing technologies.

Through this investment, Nikon aims to not only build and expand its existing technologies in observation, imaging, evaluation, and analysis via its microscope systems, but also to create new synergistic capabilities through the integration of biotechnology related to cell production.

Overview of Setsuro Tech Inc.

Company name : Setsuro Tech Inc.

Headquarters: Fujii Memorial Institute of Medical Sciences, 3-18-15, Kuramoto-cho, Tokushima-shi, Tokushima, 770-8503, JAPAN

Representative: Shinichiro Takezawa (CEO)

Business: Genome editing technology-based R&D services and commercialization of organisms with newly developed traits

( Press Release Image: https://photos.webwire.com/prmedia/7/349730/349730-1.png )


WebWireID349730





This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.